These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15002780)

  • 1. [Fibroblast growth factor 23 (FGF 23): a new fosfaturic hormone?].
    Negri AL
    Nefrologia; 2003; 23(6):478-81. PubMed ID: 15002780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibroblast growth factor 23, a new phosphaturic factor in hypophosphatemic rickets/osteomalacia].
    Nishizawa Y; Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():469-74. PubMed ID: 16279684
    [No Abstract]   [Full Text] [Related]  

  • 3. FGF23, hypophosphatemia, and rickets: has phosphatonin been found?
    Strewler GJ
    Proc Natl Acad Sci U S A; 2001 May; 98(11):5945-6. PubMed ID: 11371627
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
    Yamamoto T; Imanishi Y; Kinoshita E; Nakagomi Y; Shimizu N; Miyauchi A; Satomura K; Koshiyama H; Inaba M; Nishizawa Y; Jüppner H; Ozono K
    J Bone Miner Metab; 2005; 23(3):231-7. PubMed ID: 15838626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [X-linked hypophosphatemic vitamin D resistant rickets: Pathogenesis, pathophysiology, and therapy].
    Tanaka H
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():556-61. PubMed ID: 16523954
    [No Abstract]   [Full Text] [Related]  

  • 7. [Endocrine diseases accompanied by hypophosphatemia or hyperphosphatemia].
    Nakayama K
    Nihon Rinsho; 2006 Sep; Suppl 3():542-52. PubMed ID: 17022606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regulation of fibroblast growth factor 23 in metabolic bone diseases].
    Imanishi Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():486-91. PubMed ID: 16279687
    [No Abstract]   [Full Text] [Related]  

  • 9. PHEX, FGF23, DMP1 and beyond.
    Strom TM; Jüppner H
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):357-62. PubMed ID: 18660670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion.
    Galitzer H; Ben-Dov I; Lavi-Moshayoff V; Naveh-Many T; Silver J
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):363-7. PubMed ID: 18660671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Kida Y
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12890852
    [No Abstract]   [Full Text] [Related]  

  • 12. Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.
    Xia W; Meng X; Jiang Y; Li M; Xing X; Pang L; Wang O; Pei Y; Yu LY; Sun Y; Hu Y; Zhou X
    Calcif Tissue Int; 2007 Dec; 81(6):415-20. PubMed ID: 18046499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel regulators of phosphate homeostasis and bone metabolism.
    Jüppner H
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S3-22. PubMed ID: 17976082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cartilage abnormalities are associated with abnormal Phex expression and with altered matrix protein and MMP-9 localization in Hyp mice.
    Miao D; Bai X; Panda DK; Karaplis AC; Goltzman D; McKee MD
    Bone; 2004 Apr; 34(4):638-47. PubMed ID: 15050894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of phosphatonin in phosphate metabolism].
    Hara S; Iida R; Yoshida H; Ohkido I; Shigematsu T
    Clin Calcium; 2005 Jul; 15(7):124-30. PubMed ID: 15995308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of phosphate homeostasis in infants, children, and adolescents, and the role of phosphatonins in this process.
    Garabedian M
    Curr Opin Pediatr; 2007 Aug; 19(4):488-91. PubMed ID: 17630616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of hypophosphatemia].
    Takeuchi Y
    Clin Calcium; 2016 Feb; 26(2):199-205. PubMed ID: 26813499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assay methods for FGF].
    Ito N; Fukumoto S
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():498-502. PubMed ID: 16279689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Novel phosphate-regulating hormone, fibroblast growth factor (FGF) 23].
    Fukumoto S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():101-4. PubMed ID: 18161090
    [No Abstract]   [Full Text] [Related]  

  • 20. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.
    Sato T; Tominaga Y; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Uchida K; Nakanishi S; Kazama JJ; Gejyo F; Yamashita T; Fukagawa M
    Am J Kidney Dis; 2004 Sep; 44(3):481-7. PubMed ID: 15332221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.